BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37759328)

  • 21. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer.
    Wang Q; Liang N; Yang T; Li Y; Li J; Huang Q; Wu C; Sun L; Zhou X; Cheng X; Zhao L; Wang G; Chen Z; He X; Liu C
    J Hepatol; 2021 Nov; 75(5):1142-1153. PubMed ID: 34217777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiling of liver cancer stem cells by RNA-sequencing.
    Ho DW; Yang ZF; Yi K; Lam CT; Ng MN; Yu WC; Lau J; Wan T; Wang X; Yan Z; Liu H; Zhang Y; Fan ST
    PLoS One; 2012; 7(5):e37159. PubMed ID: 22606345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation.
    Chen G; Wang Y; Zhao X; Xie XZ; Zhao JG; Deng T; Chen ZY; Chen HB; Tong YF; Yang Z; Ding XW; Guo PY; Yu HT; Wu LJ; Zhang SN; Zhu QD; Li JJ; Shan YF; Yu FX; Yu ZP; Xia JL
    J Exp Clin Cancer Res; 2021 Jun; 40(1):218. PubMed ID: 34193219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of heat-shock protein 90 sensitizes liver cancer stem-like cells to magnetic hyperthermia and enhances anti-tumor effect on hepatocellular carcinoma-burdened nude mice.
    Yang R; Tang Q; Miao F; An Y; Li M; Han Y; Wang X; Wang J; Liu P; Chen R
    Int J Nanomedicine; 2015; 10():7345-58. PubMed ID: 26677324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.
    Liu B; Fang X; Kwong DL; Zhang Y; Verhoeft K; Gong L; Zhang B; Chen J; Yu Q; Luo J; Tang Y; Huang T; Ling F; Fu L; Yan Q; Guan XY
    J Exp Clin Cancer Res; 2022 May; 41(1):182. PubMed ID: 35610614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
    Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
    Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notch2 is a crucial regulator of self-renewal and tumorigenicity in human hepatocellular carcinoma cells.
    Wu WR; Zhang R; Shi XD; Yi C; Xu LB; Liu C
    Oncol Rep; 2016 Jul; 36(1):181-8. PubMed ID: 27221981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy.
    Yang Z; Zhao T; Liu H; Zhang L
    Sci Rep; 2016 Jan; 6():19383. PubMed ID: 26783250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.
    Sun L; Wang Y; Wang L; Yao B; Chen T; Li Q; Liu Z; Liu R; Niu Y; Song T; Liu Q; Tu K
    J Exp Clin Cancer Res; 2019 Apr; 38(1):170. PubMed ID: 30999932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrogel-based miR-192 delivery inhibits the development of hepatocellular carcinoma by suppressing the GSK3β/Wnt/β-catenin pathway.
    Yang Q; Zhuge X; Lin W; Yu W; Zhu Y; Shi C; Shi Z
    Neoplasma; 2023 Aug; 70(4):555-565. PubMed ID: 37789778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc finger protein X-linked promotes expansion of EpCAM
    Wang C; Fu SY; Wang MD; Yu WB; Cui QS; Wang HR; Huang H; Dong W; Zhang WW; Li PP; Lin C; Pan ZY; Yang Y; Wu MC; Zhou WP
    Mol Oncol; 2017 May; 11(5):455-469. PubMed ID: 28156061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR4 Influences Hepatitis B Virus Related Hepatocellular Carcinoma by Regulating the Wnt/β-Catenin Pathway.
    Yin Y; Li F; Li S; Cai J; Shi J; Jiang Y
    Cell Physiol Biochem; 2017; 42(2):469-479. PubMed ID: 28578348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Matrine suppresses stemness of hepatocellular carcinoma cells by regulating β-catenin signaling pathway].
    Dai M; Cai Z; Chen N; Li J; Wen J; Tan L; Guo D
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Oct; 39(10):1239-1245. PubMed ID: 31801708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of liver cancer in vitro and in mice by monoclonal antibody targeting epithelial specific antigen-positive liver cancer stem cells in combination with cisplatin].
    He YY; Yu L; Rong Y; Sun LX; Sun LC; Yang ZH; Ran YL; Li L
    Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):333-9. PubMed ID: 27188604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
    Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H
    J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling.
    Hu Z; Wang P; Lin J; Zheng X; Yang F; Zhang G; Chen D; Xie J; Gao Z; Peng L; Xie C
    Cell Physiol Biochem; 2018; 51(1):470-486. PubMed ID: 30453289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
    Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
    Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.